Insider Transactions Reported by 23 Insiders of Insight Molecular Diagnostics Inc.

Symbol: IMDX on Nasdaq
Location: Nashville, TN

Quick Takeaways

IMDX - Insight Molecular Diagnostics Inc. has 23 insiders with reported activity on this page.
Net insider value flow over the last year: +$11,055,380.
Recent transaction rows are available for direct filing-level review.

What Changed

Buy value: $11,055,380; sell value: $0.
Net share flow: +2,780,874.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Source Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to buying over the last 12 months. Net value: +$11,055,380.

Buys

$11,055,380

Shares: 2,780,874

Insiders: 3

Sells

Shares: 0

Insiders: 0

Net

+$11,055,380

Shares: +2,780,874

Insiders: 3

Window (months)	Buy shares	Buy $	Sell $	Net $
0-3	2,259,135	$8,055,381	$0	+$8,055,381
3-6	521,739	$2,999,999	$0	+$2,999,999
6-9	0	$0	$0	$0
9-12	0	$0	$0	$0

Insight Molecular Diagnostics Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Valuation	Report Date
BROADWOOD CAPITAL INC	10%+ Owner	$88,478,605	+$2,685,127	+3.1%	Mixed	23 Apr 2026
BROADWOOD PARTNERS, L.P.	10%+ Owner	$88,478,605	+$5,685,126	+6.9%	Mixed	23 Apr 2026
Neal C. Bradsher	10%+ Owner	$88,478,605	+$2,685,127	+3.1%	Mixed	23 Apr 2026
Patrick W. Smith	10%+ Owner	$6,679,894			Mixed	07 Feb 2025
PURA VIDA INVESTMENTS, LLC	10%+ Owner	$3,044,309			Mixed	14 Apr 2023
Andrea S. James	Chief Financial Officer	$1,777,524			Mixed	26 Mar 2026
Josh Riggs	CEO and President, Director	$674,529			Mixed	26 Mar 2026
Andrew Arno	Director	$381,104			Mixed	01 Jul 2025
John Peter Gutfreund	Former Director	$153,654			Mixed	30 Jun 2023
Ronald Asbury Andrews	Former CEO, Director	$125,332			Mixed	01 Dec 2022
Alfred D. Kingsley	Director	$109,143			Mixed	23 Jun 2023
Andrew J. Last	Director	$104,303			Mixed	01 Jul 2025
Lou Silverman	Director	$96,528			Mixed	01 Jul 2025
Gisela Paulsen	Former President and COO	$78,761			Mixed	16 Dec 2022
Li Yu	VP Cntrllr/Prncpl Acctng Offcr	$76,536			Mixed	18 May 2022
James Yang Liu	VP ACCT, Cntlr, Treasurer, PAO	$66,509			Mixed	26 Mar 2026
Ross Douglas T.	Former CSO	$50,311			Mixed	21 Dec 2022
Cavan M. Redmond	Director	$25,973			Mixed	24 Jun 2022
Mitchell S. Levine	Chief Financial Officer	$18,713			Mixed	15 Mar 2022
Jennifer Levin Carter	Director	$6,554			Mixed	15 Aug 2022
Melinda Griffith	Director	$6,447			Mixed	15 Aug 2022
Padmavathi Sundar	Chief Commercial Officer				Mixed	15 Mar 2022
Anish M. John	Chief Financial Officer				Mixed	24 Feb 2023

Top shareholders of Insight Molecular Diagnostics Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BROADWOOD CAPITAL INC	3/4/5 13F	10%+ Owner · Company	35% from 13F	25,669,954 mixed-class rows	$88,478,605	+$2,685,127	23 Apr 2026	3/4/5 13F
BROADWOOD PARTNERS, L.P.	3/4/5 13D/G	10%+ Owner · Neal C. Bradsher	40% from 13D/G	25,669,954 mixed-class rows	$88,478,605	+$5,685,126	23 Apr 2026	3/4/5 13D/G
Neal C. Bradsher	3/4/5	10%+ Owner	— mixed-class rows	25,669,954 mixed-class rows	$88,478,605	+$2,685,127	23 Apr 2026	3/4/5
AWM Investment Company, Inc.	13F 13D/G	Company	10% from 13D/G	2,814,230	$21,106,725	—	31 Dec 2025	13F 13D/G
PURA VIDA INVESTMENTS, LLC	13F 3/4/5	Company · 10%+ Owner	2.9%	947,134	$7,103,505	—	31 Dec 2025	13F 3/4/5
Patrick W. Smith	3/4/5 13D/G	10%+ Owner	10% from 13D/G	3,258,485	$6,679,894	—	07 Feb 2025	3/4/5 13D/G
VANGUARD GROUP INC	13F	Company	1.6%	526,675	$3,950,064	—	31 Dec 2025	13F
Andrea S. James	3/4/5	Chief Financial Officer	— mixed-class rows	525,965 mixed-class rows	$1,777,524	—	26 Mar 2026	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.71%	230,971	$1,733,670	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	0.41%	131,361	$985,208	—	31 Dec 2025	13F
Josh Riggs	3/4/5	CEO and President, Director	— mixed-class rows	579,874 mixed-class rows	$674,529	—	26 Mar 2026	3/4/5
BIO-RAD LABORATORIES, INC.	13D/G	—	9.7%	2,764,078	$608,097	$0	10 Feb 2025	13D/G
683 Capital Management, LLC	13F	Company	0.24%	77,204	$579,030	—	31 Dec 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.22%	72,451	$543,383	—	31 Dec 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.19%	61,377	$460,328	—	31 Dec 2025	13F
Andrew Arno	3/4/5	Director	— mixed-class rows	174,358 mixed-class rows	$381,104	—	01 Jul 2025	3/4/5
NORTHERN TRUST CORP	13F	Company	0.15%	48,858	$366,435	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.15%	47,754	$358,155	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.13%	42,469	$318,517	—	31 Dec 2025	13F
FNY Investment Advisers, LLC	13F	Company	0.13%	40,584	$304,000	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.11%	35,913	$269,348	—	31 Dec 2025	13F
Qube Research & Technologies Ltd	13F	Company	0.09%	28,351	$212,633	—	31 Dec 2025	13F
OMERS ADMINISTRATION Corp	13F	Company	0.08%	26,164	$196,230	—	31 Dec 2025	13F
OSAIC HOLDINGS, INC.	13F	Company	0.07%	24,136	$181,019	—	31 Dec 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.07%	23,965	$179,738	—	31 Dec 2025	13F
John Peter Gutfreund	3/4/5	Former Director	— mixed-class rows	760,000 mixed-class rows	$153,654	—	30 Jun 2023	3/4/5
Ronald Asbury Andrews	3/4/5	Former CEO, Director	— mixed-class rows	633,212 mixed-class rows	$125,332	—	01 Dec 2022	3/4/5
CITADEL ADVISORS LLC	13F	Company	0.05%	15,647	$117,353	—	31 Dec 2025	13F
Alfred D. Kingsley	3/4/5	Director	— mixed-class rows	597,878 mixed-class rows	$109,143	—	23 Jun 2023	3/4/5
Andrew J. Last	3/4/5	Director	— mixed-class rows	69,509 mixed-class rows	$104,303	—	01 Jul 2025	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.04%	13,400	$100,500	—	31 Dec 2025	13F
Hudson Bay Capital Management LP	13F	Company	0.04%	13,061	$97,958	—	31 Dec 2025	13F
Lou Silverman	3/4/5	Director	— mixed-class rows	66,564 mixed-class rows	$96,528	—	01 Jul 2025	3/4/5
Gisela Paulsen	3/4/5	Former President and COO	— class O/S missing	366,500	$78,761	—	16 Dec 2022	3/4/5
Private Advisor Group, LLC	13F	Company	0.03%	10,416	$78,120	—	31 Dec 2025	13F
Li Yu	3/4/5	VP Cntrllr/Prncpl Acctng Offcr	— mixed-class rows	41,872 mixed-class rows	$76,536	—	18 May 2022	3/4/5
James Yang Liu	3/4/5	VP ACCT, Cntlr, Treasurer, PAO	— mixed-class rows	34,289 mixed-class rows	$66,509	—	26 Mar 2026	3/4/5
Ross Douglas T.	3/4/5	Former CSO	— class O/S missing	234,114	$50,311	—	21 Dec 2022	3/4/5
EverSource Wealth Advisors, LLC	13F	Company	0.02%	5,000	$37,500	—	31 Dec 2025	13F
Cavan M. Redmond	3/4/5	Director	— class O/S missing	120,863	$25,973	—	24 Jun 2022	3/4/5
UBS Group AG	13F	Company	0.01%	2,941	$22,058	—	31 Dec 2025	13F
Mitchell S. Levine	3/4/5	Chief Financial Officer	— mixed-class rows	174,580 mixed-class rows	$18,713	—	15 Mar 2022	3/4/5
Jennifer Levin Carter	3/4/5	Director	— mixed-class rows	75,500 mixed-class rows	$6,554	—	15 Aug 2022	3/4/5
Melinda Griffith	3/4/5	Director	— mixed-class rows	75,000 mixed-class rows	$6,447	—	15 Aug 2022	3/4/5
ORG Partners LLC	13F	Company	0%	450	$3,375	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	335	$2,513	—	31 Dec 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	250	$1,875	—	31 Dec 2025	13F
SBI Securities Co., Ltd.	13F	Company	0%	185	$1,388	—	31 Dec 2025	13F
JPMORGAN CHASE & CO	13F	Company	0%	154	$1,155	—	31 Dec 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	30	$225	—	31 Dec 2025	13F

Recent Insider Transactions by Companies or Individuals for Insight Molecular Diagnostics Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,684,884	27 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,684,884	27 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,684,884	27 Apr 2026	Footnote
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase	2.02%	$913,134	$3.64	250,923	12,684,884	27 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	2.02%	$913,134	$3.64	250,923	12,684,884	27 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	2.02%	$913,134	$3.64	250,923	12,684,884	27 Apr 2026	Direct
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,433,961	24 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,433,961	24 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,433,961	24 Apr 2026	Footnote
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase	0.31%	$137,083	$3.53	38,880	12,433,961	24 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	0.31%	$137,083	$3.53	38,880	12,433,961	24 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	0.31%	$137,083	$3.53	38,880	12,433,961	24 Apr 2026	Direct
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,395,081	23 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,395,081	23 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,395,081	23 Apr 2026	Footnote
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase	2.31%	$982,034	$3.50	280,381	12,395,081	23 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	2.31%	$982,034	$3.50	280,381	12,395,081	23 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	2.31%	$982,034	$3.50	280,381	12,395,081	23 Apr 2026	Direct
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,114,700	20 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,114,700	20 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,114,700	20 Apr 2026	Footnote
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase	0.34%	$157,967	$3.88	40,690	12,114,700	20 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	0.34%	$157,967	$3.88	40,690	12,114,700	20 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	0.34%	$157,967	$3.88	40,690	12,114,700	20 Apr 2026	Direct
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,074,010	17 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,074,010	17 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,074,010	17 Apr 2026	Footnote
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase	0.33%	$143,251	$3.57	40,114	12,074,010	17 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	0.33%	$143,251	$3.57	40,114	12,074,010	17 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	0.33%	$143,251	$3.57	40,114	12,074,010	17 Apr 2026	Direct
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,033,896	16 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,033,896	16 Apr 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	12,033,896	16 Apr 2026	Footnote
BROADWOOD PARTNERS, L.P.	IMDX	Common Stock, no par value	Purchase	0.86%	$351,658	$3.45	102,057	12,033,896	16 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	0.86%	$351,658	$3.45	102,057	12,033,896	16 Apr 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	0.86%	$351,658	$3.45	102,057	12,033,896	16 Apr 2026	Direct
Andrea S. James	IMDX	Common Stock	Tax liability	-5.2%			-11,298	206,060	26 Mar 2026	Direct
Andrea S. James	IMDX	Common Stock	Options Exercise	15%			28,302	217,358	26 Mar 2026	Direct
Andrea S. James	IMDX	Restricted Stock Units	Options Exercise	-25%			-28,302	84,905	26 Mar 2026	Direct
James Yang Liu	IMDX	Common Stock	Tax liability	-41%			-2,578	3,711	26 Mar 2026	Direct
James Yang Liu	IMDX	Common Stock	Options Exercise				6,289	6,289	26 Mar 2026	Direct
James Yang Liu	IMDX	Restricted Stock Units	Options Exercise	-33.3%			-6,289	12,578	26 Mar 2026	Direct
Josh Riggs	IMDX	Common Stock	Tax liability	-24.3%			-12,310	38,365	26 Mar 2026	Direct
Josh Riggs	IMDX	Common Stock	Options Exercise	1345.8%			47,170	50,675	26 Mar 2026	Direct
Josh Riggs	IMDX	Restricted Stock Units	Options Exercise	-25%			-47,170	141,509	26 Mar 2026	Direct
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase				0	11,931,839	10 Feb 2026	Footnote
Broadwood Partners, L.P.	IMDX	Common Stock, no par value	Purchase	4.57%	$2,999,999	$5.75	521,739	11,931,839	10 Feb 2026	Direct
Andrea S. James	OCX	Common Stock	Tax liability	-6.05%			-12,175	189,056	31 Oct 2025	Direct
Andrea S. James	OCX	Common Stock	Options Exercise	33.1%			50,000	201,231	31 Oct 2025	Direct
Andrea S. James	OCX	Restricted Stock Units	Options Exercise	-50%			-50,000	50,000	31 Oct 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.